Plasma Neuropeptide-S Levels in Populations Diagnosed with Generalized Anxiety Disorder: A Controlled Study.

Journal: Noro psikiyatri arsivi
Published Date: Apr 20, 2018

Abstract

INTRODUCTION: Neuropeptide S (NPS) is a novel neuropeptide reported to be involved in fear-and stress-related conditions and their corresponding neuroendocrine processes. The aim of this study was to compare the plasma NPS levels in patients suffering from generalized anxiety disorder (GAD) and those of healthy controls.

Authors

  • Hayriye Baykan
    Department of Psychiatry, Balıkesir University Faculty of Medicine, Balıkesir, Turkey.
  • Özgür Baykan
    Department of Clinical Biochemisty, Balıkesir Atatürk State Hospital, Balıkesir, Turkey.
  • Onur Durmaz
    Department of Psychiatry, Erenköy Mental Health and Neurology Research and Training Hospital, İstanbul, Turkey.
  • Hayrettin Kara
    Department of Clinical Biochemistry, Balıkesir University Faculty of Medicine, Balıkesir, Turkey.
  • Adnan Adil Hişmioğullari
    Department of Clinical Biochemistry, Balıkesir University Faculty of Medicine, Balıkesir, Turkey.
  • Tunay Karlidere
    Department of Psychiatry, Balıkesir University Faculty of Medicine, Balıkesir, Turkey.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals